Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J S K, Au"'
Autor:
Petr Zatloukal, Maria Blasinska-Morawiec, Sandra J. Meech, Jacek Jassem, Nick Thatcher, Christian Manegold, Rebecca J. Benner, N. van Zandwijk, Eng Huat Tan, A. Ingrosso, Piotr Serwatowski, Maciej Krzakowski, David Robert John Readett, Aleksandra Szczesna, J. S.-K. Au
Publikováno v:
Annals of Oncology. 23:72-77
Background This open-label phase III study assessed the addition of Toll-like receptor 9-activating oligodeoxynucleotide PF-3512676 to gemcitabine/cisplatin chemotherapy in patients with non-small-cell lung cancer (NSCLC). Patients and methods Chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4b644b42c5fb46097d8cebcd58d6a1
https://doi.org/10.1093/annonc/mdr030
https://doi.org/10.1093/annonc/mdr030
Publikováno v:
British Journal of Cancer
Tobacco smoking is the most important risk factor for lung cancer (IARC, 2004), contributing around 80% of lung cancer cases of European men and 58% of Chinese men (Tse et al, 2009a). Other risk factors include occupational exposures to suspected car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0688abe0613952e0e5a8216ccb721b5
https://doi.org/10.1038/sj.bjc.6606006
https://doi.org/10.1038/sj.bjc.6606006
Publikováno v:
Annals of Oncology. 20:746-751
We conducted this case-control study to evaluate smoking effect on lung cancer conditional on the level of exposure to cooking emissions and to explore whether there is a joint effect of these two risk factors.We selected 279 newly diagnosed primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::562890b503c25d3e59cf2158c689b27d
https://doi.org/10.1093/annonc/mdn699
https://doi.org/10.1093/annonc/mdn699
Autor:
M. Akimov, Sergey Orlov, C. Hillenbach, H.-P. Kuo, Martin Reck, J. S.-K. Au, Paul Delmar, Rodryg Ramlau, Enriqueta Felip, Janusz Milanowski, A. Pluzanska, D. Damyanov, Pan-Chyr Yang, Barbara Klughammer, Laurent Essioux, José Baselga, Eng Huat Tan, Patricia Mcloughlin
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Annals of Oncology
Universitat Autònoma de Barcelona
Annals of Oncology
Background: Identification of appropriate markers for predicting clinical benefit with erlotinib in non-small-cell lung cancer (NSCLC) may be able to guide patient selection for treatment. This open-label, multicentre, phase II trial aimed to identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd58a632187bfdea5cc811c06466737
https://ddd.uab.cat/record/108162
https://ddd.uab.cat/record/108162
Autor:
A W M, Lee, J S K, Au, P M L, Teo, T W, Leung, D T T, Chua, W M, Sze, B C Y, Zee, S C K, Law, S F, Leung, S Y, Tung, D L W, Kwong, W H, Lau
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 16(4)
To evaluate the current UICC/AJCC Staging System for nasopharyngeal carcinoma and to search for ways of improving the system.This is a retrospective analysis of 2687 consecutive patients treated in five public centres in Hong Kong during the period 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::866273b699e2053ccc7883c288d1af22
https://pubmed.ncbi.nlm.nih.gov/15630856
https://pubmed.ncbi.nlm.nih.gov/15630856